| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7b939923054cc7a3154626bd82fd7e6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-828
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-144444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2326-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2326-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2326-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-42 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-526 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 |
| filingDate |
1996-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60fb8614ca575c3983a8f218dc5d399e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_208cd5caedc0d96ec4b36699ba641fe0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34614aa6f63c2034de24cdc4f19c34c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce2e5ad9f4e79476147792ec36ec295c |
| publicationDate |
1996-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2215914-A1 |
| titleOfInvention |
Combined assay for current glucose level and intermediate or long-term glycemic control |
| abstract |
The present invention is directed to a single test system and method for determining the integrated glycemic condition of a subject by measuring the concentration of glucose and the level of protein-bound glucose in a subject's body fluid, such as whole blood. The glucose concentration is indicative of the subject's immediate glycemic condition, whereas the protein-bound glucose concentration is indicative of either intermediate or long-term glycemic condition. Optionally, other analytes indicative of glycemie condition, such as ketone bodies or fatty acid derivatives, can also be measured. The present invention also provides a method of diagnosing diabetes. The invention additionally provides a method for analyzing the concentration of fructosamine in less than or equal to five minutes without the use of a reaction accelerator. |
| priorityDate |
1995-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |